Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want – again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

The Specials Laboratory
Unit 1 Regents Drive Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
01661 831 811
Contact The Specials Laboratory
Website

 Latest Content from PMHub 

Removing the Roadblocks to Effective Patient Treatment

White Papers and Resources | November 22, 2013 | Inizio

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

White Papers and Resources | November 22, 2013 | Inizio

Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

The Difficulties of Living with Depression Don’t End with the Illness Itself

White Papers and Resources | November 22, 2013 | Inizio

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

Patient Power: Too Much of a Good Thing?

White Papers and Resources | November 22, 2013 | Inizio

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding

He who dares wins

White Papers and Resources | November 15, 2013 | Lucid Group Communications Limited

The benefits of including medical experts in your brand planning team

Guide to Customer Experience for Pharma

White Papers and Resources | November 5, 2013 | Blue Latitude Health

Find out how to overcome your customer experience challenges

Does your medical education drive change in clinical practice?

White Papers and Resources | October 18, 2013 | Lucid Group Communications Limited

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Advance the way you work with your experts

White Papers and Resources | September 25, 2013 | Lucid Group Communications Limited

Written by Jan Steele PhD, operations director, Lucid

Pharmacovigilance and adverse event reporting: Five keys for establishing worldwide best practice

White Papers and Resources | September 19, 2013 | Merrill Brink International

Pharmacovigilance, an arm of patient care with a charter to make the best use of medicines and data for the treatment or prevention of disease, is taking on growing importance...

Ensuring you are EU Medical Device e-labelling compliant – A best practice strategy

White Papers and Resources | September 19, 2013 | Merrill Brink International

The EU Directive No 207/2012 on electronic labelling for Instructions for Use (IFUs) for certain medical devices was adopted effective March 9, 2012.